Main Session
Sep
29
SS 40 - Evolving Paradigms in High-Risk Breast Cancer: Optimization and Integration of Treatment Modalities Across the Disease Continuum
320 - Simultaneous Integrated Boost in Hypofractionated Regional Lymph Node Irradiotherapy for cN3 Breast Cancer: Preliminary Report of a Prospective Phase 2 Single-Arm Trial
Presenter(s)
Yutong Tan, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Shenzhen, Guangdong